Diagnostic Consultative Centre Ascendent OOD

The medical center is at the forefront of research in Severe Hypertriglyceridemia, focusing on innovative treatments to manage this condition. The center's research aims to significantly reduce fasting serum triglyceride levels, thereby improving patient outcomes and quality of life.

• Advanced lipid management therapies
• Metabolic syndrome interventions
• Cardiovascular risk reduction

Through the ENTRUST study, the center is pioneering the use of pegozafermin, a promising therapeutic agent, to address the challenges posed by severe hypertriglyceridemia.

Specializing in axial spondyloarthritis, the medical center is dedicated to advancing treatment options for this chronic inflammatory disease. The research focuses on alleviating the signs and symptoms associated with the condition, enhancing patient mobility and comfort.

• Innovative anti-inflammatory treatments
• Joint health and mobility improvement
• Long-term disease management strategies

The center's work with filgotinib is a testament to its commitment to developing effective therapies that offer relief and improved quality of life for those affected by axial spondyloarthritis.

Focusing on endometriosis-related pain, the medical center is leading research efforts to provide relief for individuals suffering from this debilitating condition. The center's studies aim to reduce overall pelvic pain and improve daily functioning for patients.

• Comprehensive pain management solutions
• Hormonal therapy advancements
• Patient-centered care approaches

Through the investigation of OG-6219, the center is exploring new avenues for effective pain management, offering hope to those affected by moderate to severe endometriosis-related pain.